Cite
Immunological characterization of HM5023507, an orally active PI3Kδ/γ inhibitor
MLA
Yu Cai, et al. “Immunological Characterization of HM5023507, an Orally Active PI3Kδ/γ Inhibitor.” Pharmacology Research & Perspectives, vol. 8, no. 1, Feb. 2020. EBSCOhost, https://doi.org/10.1002/prp2.559.
APA
Yu Cai, Jun Yu, Ping Ren, Jianlin He, Zhipeng Wu, Kun Xiao, Hong Jia, Jian Wang, Yang Sai, Guangxiu Dai, Xiong Li, Weiguo Su, Karen Ngo, Glenda Castro, Paul D. Acton, Wai‐Ping Fung‐Leung, James P. Edwards, Jennifer Venable, & Tadimeti S. Rao. (2020). Immunological characterization of HM5023507, an orally active PI3Kδ/γ inhibitor. Pharmacology Research & Perspectives, 8(1). https://doi.org/10.1002/prp2.559
Chicago
Yu Cai, Jun Yu, Ping Ren, Jianlin He, Zhipeng Wu, Kun Xiao, Hong Jia, et al. 2020. “Immunological Characterization of HM5023507, an Orally Active PI3Kδ/γ Inhibitor.” Pharmacology Research & Perspectives 8 (1). doi:10.1002/prp2.559.